FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3193593943> ?p ?o ?g. }

• W3193593943 endingPage "100221" @default.
• W3193593943 startingPage "100221" @default.
• W3193593943 abstract "Neoadjuvant immunotherapy may improve outcomes in patients with resectable NSCLC and is being evaluated in phase 2 and 3 studies. Nevertheless, preoperative treatment postpones resection; the potential for increased surgical complexity and greater intra- and postoperative morbidity and mortality is an additional consideration. In studies primarily designed to evaluate efficacy, the impact of neoadjuvant immunotherapy on surgery is based on parameters that are poorly defined and reported differently between studies. Defining and reporting common end points among trials would improve understanding and facilitate cross-comparison of different immunotherapy regimens and may facilitate wider adoption of induction therapies by surgeons and oncologists. We propose several surgical end points and related metrics for neoadjuvant immunotherapy in resectable NSCLC. These include the periods from screening to treatment initiation and from last neoadjuvant dose to surgery; reporting of the allowable window for surgery to preclude masking delays caused by induction treatment-related toxicity; complete resection (R0) rate; preoperative downstaging; a standardized list of immune-related adverse events and associated delay to surgery; preoperative attrition; postoperative attrition before adjuvant therapy; and postoperative 30- and 90-day mortality and morbidity rates. Intraoperative end points (blood loss, duration, and type of surgery) and our proposed system of grading complexity based on lymphadenopathy and fibrosis would allow quantitation of technical difficulty and quality of oncologic resection. In conclusion, the standardization, reporting, and prospective inclusion of these end points in study protocols would provide a comparative overview of the impact of different neoadjuvant immunotherapy regimens on surgery and ultimately clinical oncologic outcomes in resectable NSCLC." @default.
• W3193593943 created "2021-08-30" @default.
• W3193593943 creator A5002656601 @default.
• W3193593943 creator A5016050402 @default.
• W3193593943 creator A5032753570 @default.
• W3193593943 creator A5038193321 @default.
• W3193593943 creator A5044795397 @default.
• W3193593943 creator A5045498137 @default.
• W3193593943 creator A5069871091 @default.
• W3193593943 creator A5091656031 @default.
• W3193593943 date "2021-10-01" @default.
• W3193593943 modified "2023-10-04" @default.
• W3193593943 title "Important Surgical and Clinical End Points in Neoadjuvant Immunotherapy Trials in Resectable NSCLC" @default.
• W3193593943 cites W1954745527 @default.
• W3193593943 cites W2009998041 @default.
• W3193593943 cites W2038716687 @default.
• W3193593943 cites W2058051527 @default.
• W3193593943 cites W2114238186 @default.
• W3193593943 cites W2120844381 @default.
• W3193593943 cites W2128147114 @default.
• W3193593943 cites W2134291074 @default.
• W3193593943 cites W2153169173 @default.
• W3193593943 cites W2157105206 @default.
• W3193593943 cites W2160708645 @default.
• W3193593943 cites W2168365588 @default.
• W3193593943 cites W2169351454 @default.
• W3193593943 cites W2228313244 @default.
• W3193593943 cites W2229975485 @default.
• W3193593943 cites W2527748695 @default.
• W3193593943 cites W2569624281 @default.
• W3193593943 cites W2756648224 @default.
• W3193593943 cites W2774909809 @default.
• W3193593943 cites W2782898385 @default.
• W3193593943 cites W2786816161 @default.
• W3193593943 cites W2800970549 @default.
• W3193593943 cites W2802047808 @default.
• W3193593943 cites W2892483359 @default.
• W3193593943 cites W2893321040 @default.
• W3193593943 cites W2905289065 @default.
• W3193593943 cites W2946867117 @default.
• W3193593943 cites W2947975201 @default.
• W3193593943 cites W2972642313 @default.
• W3193593943 cites W2977484833 @default.
• W3193593943 cites W2981353436 @default.
• W3193593943 cites W2981374212 @default.
• W3193593943 cites W2982617740 @default.
• W3193593943 cites W2991025431 @default.
• W3193593943 cites W2999042597 @default.
• W3193593943 cites W3005124847 @default.
• W3193593943 cites W3012770963 @default.
• W3193593943 cites W3015451486 @default.
• W3193593943 cites W3017206354 @default.
• W3193593943 cites W3021010739 @default.
• W3193593943 cites W3021212023 @default.
• W3193593943 cites W3030273927 @default.
• W3193593943 cites W3085588450 @default.
• W3193593943 cites W3088673044 @default.
• W3193593943 cites W3097511760 @default.
• W3193593943 cites W3120186925 @default.
• W3193593943 cites W3170024542 @default.
• W3193593943 cites W3178128501 @default.
• W3193593943 cites W3179257167 @default.
• W3193593943 doi "https://doi.org/10.1016/j.jtocrr.2021.100221" @default.
• W3193593943 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8552106" @default.
• W3193593943 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34746882" @default.
• W3193593943 hasPublicationYear "2021" @default.
• W3193593943 type Work @default.
• W3193593943 sameAs 3193593943 @default.
• W3193593943 citedByCount "12" @default.
• W3193593943 countsByYear W31935939432021 @default.
• W3193593943 countsByYear W31935939432022 @default.
• W3193593943 countsByYear W31935939432023 @default.
• W3193593943 crossrefType "journal-article" @default.
• W3193593943 hasAuthorship W3193593943A5002656601 @default.
• W3193593943 hasAuthorship W3193593943A5016050402 @default.
• W3193593943 hasAuthorship W3193593943A5032753570 @default.
• W3193593943 hasAuthorship W3193593943A5038193321 @default.
• W3193593943 hasAuthorship W3193593943A5044795397 @default.
• W3193593943 hasAuthorship W3193593943A5045498137 @default.
• W3193593943 hasAuthorship W3193593943A5069871091 @default.
• W3193593943 hasAuthorship W3193593943A5091656031 @default.
• W3193593943 hasBestOaLocation W31935939431 @default.
• W3193593943 hasConcept C121608353 @default.
• W3193593943 hasConcept C126322002 @default.
• W3193593943 hasConcept C127413603 @default.
• W3193593943 hasConcept C141071460 @default.
• W3193593943 hasConcept C143998085 @default.
• W3193593943 hasConcept C147176958 @default.
• W3193593943 hasConcept C203092338 @default.
• W3193593943 hasConcept C2777286243 @default.
• W3193593943 hasConcept C2777701055 @default.
• W3193593943 hasConcept C2778292576 @default.
• W3193593943 hasConcept C530470458 @default.
• W3193593943 hasConcept C535046627 @default.
• W3193593943 hasConcept C71924100 @default.
• W3193593943 hasConceptScore W3193593943C121608353 @default.
• W3193593943 hasConceptScore W3193593943C126322002 @default.
• W3193593943 hasConceptScore W3193593943C127413603 @default.

• next